Immediate Impact
58 standout
Citing Papers
Pancreatic cancer
2025 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Shen‐Nien Wang being referenced
Efficacy of sorafenib as adjuvant therapy to prevent early recurrence of hepatocellular carcinoma after curative surgery: A pilot study
2013
Temporal trends and volume-outcome associations in periampullary cancer patients: a propensity score–adjusted nationwide population-based study
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shen‐Nien Wang | 339 | 279 | 172 | 182 | 32 | 767 | |
| Munenori Tahara | 317 | 314 | 207 | 190 | 32 | 883 | |
| Jun‐Hua Lu | 395 | 355 | 209 | 235 | 33 | 983 | |
| Naritaka Yamamoto | 410 | 370 | 110 | 172 | 28 | 698 | |
| Christoph Jüngst | 241 | 264 | 151 | 305 | 37 | 789 | |
| Simon H. Y. Tsang | 351 | 221 | 195 | 258 | 38 | 728 | |
| Xiaodong Wang | 339 | 160 | 82 | 216 | 47 | 734 | |
| Daichi Takizawa | 393 | 201 | 157 | 258 | 57 | 798 | |
| Eduardo E. Montalvo‐Javé | 216 | 372 | 100 | 131 | 50 | 783 | |
| Ayman Ibrahim | 260 | 212 | 102 | 230 | 21 | 823 | |
| Toshihiko Kurohiji | 356 | 265 | 165 | 172 | 41 | 968 |
All Works
Login with ORCID to disown or claim papers
Loading papers...